AUSPEX PHARMACEUTICALS, INC. LOAN AND SECURITY AGREEMENTLoan and Security Agreement • December 20th, 2013 • Auspex Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledDecember 20th, 2013 Company Industry JurisdictionThis LOAN AND SECURITY AGREEMENT (the “Agreement”) is entered into as of January 9, 2013, by and between Square 1 Bank (“Bank”) and AUSPEX PHARMACEUTICALS, INC. (“Borrower”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • December 20th, 2013 • Auspex Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 20th, 2013 Company Industry JurisdictionTHIS INDEMNIFICATION AGREEMENT (this “Agreement”) dated as of , is made by and between AUSPEX PHARMACEUTICALS, INC., A DELAWARE CORPORATION (THE “Company”), and (“Indemnitee”).
AUSPEX PHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT December 20, 2013Investors’ Rights Agreement • December 20th, 2013 • Auspex Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 20th, 2013 Company Industry JurisdictionThis Amended and Restated Investors’ Rights Agreement (the “Agreement”) is made as of December 20, 2013, by and among Auspex Pharmaceuticals, Inc., a Delaware corporation (the “Company”), the holders of the Company’s Series A-1, Series A-2, Series A-3, Series A-4 and Series A-5 Preferred Stock set forth on Exhibit A attached hereto (the “Series A Holders”), the holders of Series B Preferred Stock set forth on Exhibit A attached hereto (the “Series B Holders”), the holders of Series C Preferred Stock set forth on Exhibit A attached hereto (the “Series C Holders”), the holders of Series D Preferred Stock set forth on Exhibit A attached hereto (the “Series D Holders”) and the holders of Series E Preferred Stock set forth on Exhibit A attached hereto (the “Series E Holders,” and together with the Series A Holders, the Series B Holders, the Series C Holders and the Series D Holders, the “Investors”).
ContractAuspex Pharmaceuticals, Inc. • December 20th, 2013 • Pharmaceutical preparations • California
Company FiledDecember 20th, 2013 Industry JurisdictionTHIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED.
February 23, 2012 Dr. David Stamler Via Email: dstamler@auspexpharma.com Dear David:Auspex Pharmaceuticals, Inc. • December 20th, 2013 • Pharmaceutical preparations
Company FiledDecember 20th, 2013 IndustryThis letter will confirm our discussions regarding your Employment Agreement dated February 4, 2011 as amended on August 25, 2011 and will make the following changes effective January 15, 2012.
FIRST AMENDMENT TO LEASELease • December 20th, 2013 • Auspex Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 20th, 2013 Company IndustryTHIS FIRST AMENDMENT TO LEASE (“First Amendment”) is made and entered into as of the 21st day of June, 2012, by and between MULLROCK 3 TORREY PINES, LLC, a Delaware limited liability company (“Landlord”) and AUSPEX PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).